652 related articles for article (PubMed ID: 19453349)
1. Sources of drug information: FDA-approved labeling and other official FDA sources.
Lindstrom JA
Dermatol Ther; 2009; 22(3):246-56. PubMed ID: 19453349
[TBL] [Abstract][Full Text] [Related]
2. Drugs and other product choices.
Hyman PM; Carvajal R
Dermatol Ther; 2009; 22(3):216-24. PubMed ID: 19453345
[TBL] [Abstract][Full Text] [Related]
3. Requirements on content and format of labeling for human prescription drug and biological products. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2006 Jan; 71(15):3921-97. PubMed ID: 16479698
[TBL] [Abstract][Full Text] [Related]
4. Generic drugs--safe, effective, and affordable.
Peters JR; Hixon DR; Conner DP; Davit BM; Catterson DM; Parise CM
Dermatol Ther; 2009; 22(3):229-40. PubMed ID: 19453347
[TBL] [Abstract][Full Text] [Related]
5. Off-label uses of biologic agents in dermatology: a 2006 update.
Kerns MJ; Graves JE; Smith DI; Heffernan MP
Semin Cutan Med Surg; 2006 Dec; 25(4):226-40. PubMed ID: 17174843
[TBL] [Abstract][Full Text] [Related]
6. Finding, evaluating, and managing drug-related risks: approaches taken by the US Food and Drug Administration (FDA).
Weaver J; Grenade LL; Kwon H; Avigan M
Dermatol Ther; 2009; 22(3):204-15. PubMed ID: 19453344
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use.
Frueh FW; Amur S; Mummaneni P; Epstein RS; Aubert RE; DeLuca TM; Verbrugge RR; Burckart GJ; Lesko LJ
Pharmacotherapy; 2008 Aug; 28(8):992-8. PubMed ID: 18657016
[TBL] [Abstract][Full Text] [Related]
8. Food and Drug Administration surveillance of dermatology-related and nondermatology-related prescription drug advertising in the USA, 2000-2003.
Cowden AL; Katz KA
Br J Dermatol; 2006 May; 154(5):950-8. PubMed ID: 16634900
[TBL] [Abstract][Full Text] [Related]
9. An overview of the FDA publication Approved Drug Products with Therapeutic Equivalence Evaluations.
Knoben JE; Scott GR; Tonelli RJ
Am J Hosp Pharm; 1990 Dec; 47(12):2696-700. PubMed ID: 2278285
[TBL] [Abstract][Full Text] [Related]
10. The new Food and Drug Administration drug package insert: implications for patient safety and clinical care.
Watson KT; Barash PG
Anesth Analg; 2009 Jan; 108(1):211-8. PubMed ID: 19095852
[TBL] [Abstract][Full Text] [Related]
11. Can claims, misleading information, and manufacturing issues regarding dietary supplements be improved in the United States?
Gibson JE; Taylor DA
J Pharmacol Exp Ther; 2005 Sep; 314(3):939-44. PubMed ID: 15833895
[TBL] [Abstract][Full Text] [Related]
12. Current FDA directives for promoting public health.
Hayes AH
Am J Hosp Pharm; 1982 Mar; 39(3):427-31. PubMed ID: 7072727
[TBL] [Abstract][Full Text] [Related]
13. Skin protectant drug products for over-the-counter human use; final monograph; technical amendment. Final rule; technical amendment.
Food and Drug Administration, HHS
Fed Regist; 2003 Dec; 68(236):68509-11. PubMed ID: 14664244
[TBL] [Abstract][Full Text] [Related]
14. Requirements for submission of labeling for human prescription drugs and biologics in electronic format. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2003 Dec; 68(238):69009-20. PubMed ID: 14672084
[TBL] [Abstract][Full Text] [Related]
15. Content and format for labeling for human prescription drugs; amendment of effective date for certain biological products--Food and Drug Administration. Final rule.
Fed Regist; 1981 Jan; 46(15 pt 1):7271-3. PubMed ID: 10249526
[TBL] [Abstract][Full Text] [Related]
16. FDA reform in Congress: AIDS community absent. Food and Drug Administration.
James JS
AIDS Treat News; 1995 Apr; (no 220):4-5. PubMed ID: 11362320
[TBL] [Abstract][Full Text] [Related]
17. What is prescription labeling communicating to doctors about hepatotoxic drugs? A study of FDA approved product labeling.
Willy ME; Li Z
Pharmacoepidemiol Drug Saf; 2004 Apr; 13(4):201-6. PubMed ID: 15255086
[TBL] [Abstract][Full Text] [Related]
18. How should FDA regulate prescription drug promotion on the Internet?
Opderbeck DW
Food Drug Law J; 1998; 53(1):47-61. PubMed ID: 11795336
[TBL] [Abstract][Full Text] [Related]
19. Pharmaceutical provisions of the FDA Modernization Act of 1997: one year and counting.
Binder GM
Curr Opin Biotechnol; 1999 Jun; 10(3):303-6. PubMed ID: 10361077
[TBL] [Abstract][Full Text] [Related]
20. Focus on: information technology. Online drug information for dermatology patients.
Oakley A
J Drugs Dermatol; 2005; 4(1):108-13. PubMed ID: 15696997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
